Ligand Pharmaceuticals
LGND
#4143
Rank
A$3.46 B
Marketcap
$183.53
Share price
0.61%
Change (1 day)
76.11%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.51. In 2022 the company made an earnings per share (EPS) of -$3.17 a decrease over its 2021 EPS that were of $5.54.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-174.49%
2022-$3.17-157.23%
2021$5.54-2571.43%
2020-$0.22-100.46%
2019$49.00353.48%
2018$10.811025%
2017$0.96-700%
2016-$0.16-100.87%
2015$18.511859.32%
2014$0.945.36%
2013$0.908.0704505322479E+18%
2012$0.0000000000-100%
2011$0.78-194.23%
2010-$0.83548.38%
2009-$0.13-98.7%
2008-$9.89-136.52%
2007$27.09-787.8%
2006-$3.94-14.58%
2005-$4.61-21.31%
2004-$5.86-55.15%
2003-$13.0681.33%
2002-$7.202.74%
2001-$7.01-45.93%
2000-$12.97-14.56%
1999-$15.18-45.52%
1998-$27.86-3.97%
1997-$29.01132.31%
1996-$12.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.65 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.58-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.60 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.92 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.98 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.69 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.36 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.20 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.55 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA